Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTISK KLINIK RØDBY ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   3.0% 2.7% 2.5% 2.7% 2.0% 2.6% 9.3% 9.3%   Credit score (0-100)   58 60 61 60 68 62 27 27   Credit rating   BBB BBB BBB BBB A BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,688 3,491 3,408 2,651 3,076 3,838 0.0 0.0   EBITDA   252 647 1,136 360 645 542 0.0 0.0   EBIT   -1.8 370 859 45.9 364 249 0.0 0.0   Pre-tax profit (PTP)   199.5 383.7 1,157.9 105.7 432.5 385.4 0.0 0.0   Net earnings   153.9 298.9 901.6 86.3 338.6 294.4 0.0 0.0   Pre-tax profit without non-rec. items   200 384 1,158 106 432 385 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   795 1,008 957 150 292 590 0.0 0.0   Shareholders equity total   3,839 4,038 4,839 4,826 5,064 5,259 58.8 58.8   Interest-bearing liabilities   73.0 89.1 0.0 54.7 94.7 0.0 841 841   Balance sheet total (assets)   4,863 4,862 5,462 5,363 5,563 5,851 900 900   Net Debt   -1,922 -1,919 -291 -286 -562 -498 841 841     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,688 3,491 3,408 2,651 3,076 3,838 0.0 0.0   Gross profit growth   -5.8% -5.3% -2.4% -22.2% 16.0% 24.8% -100.0% 0.0%   Employees   0 0 0 0 5 5 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,863 4,862 5,462 5,363 5,563 5,851 900 900   Balance sheet change%   2.0% -0.0% 12.3% -1.8% 3.7% 5.2% -84.6% 0.0%   Added value   251.7 646.7 1,136.0 360.3 678.3 542.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   211 -288 -553 -1,346 -364 -221 -590 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -0.0% 10.6% 25.2% 1.7% 11.8% 6.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   4.3% 7.9% 22.5% 2.0% 7.9% 6.8% 0.0% 0.0%   ROI %   4.7% 8.7% 23.9% 2.1% 8.2% 7.1% 0.0% 0.0%   ROE %   4.0% 7.6% 20.3% 1.8% 6.8% 5.7% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   78.9% 83.0% 88.6% 90.0% 91.0% 89.9% 6.5% 6.5%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -763.4% -296.7% -25.6% -79.4% -87.1% -91.8% 0.0% 0.0%   Gearing %   1.9% 2.2% 0.0% 1.1% 1.9% 0.0% 1,431.3% 1,431.3%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   12.5% 3.4% 7.4% 11.1% 0.0% 2.1% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   3.5 4.9 11.0 15.7 16.6 11.8 0.0 0.0   Current Ratio   3.5 4.9 11.0 15.8 16.7 11.8 0.0 0.0   Cash and cash equivalent   1,994.7 2,007.8 290.7 341.0 656.6 498.2 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -124.6 44.8 2,663.1 3,617.8 3,896.8 3,993.0 -420.6 -420.6   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 136 108 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 129 108 0 0   EBIT / employee   0 0 0 0 73 50 0 0   Net earnings / employee   0 0 0 0 68 59 0 0